US Stock MarketDetailed Quotes

Karyopharm Therapeutics (KPTI)

Watchlist
  • 6.590
  • -0.050-0.75%
Close Jan 23 16:00 ET
  • 6.590
  • 0.0000.00%
Post 16:10 ET
120.66MMarket Cap-0.46P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Karyopharm Therapeutics (KPTI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
13.57%44.04M
-11.35%37.93M
-9.39%30.02M
-0.55%145.24M
-9.50%30.54M
7.70%38.78M
13.86%42.79M
-14.40%33.13M
-7.03%146.03M
0.50%33.75M
Operating revenue
13.57%44.04M
-11.35%37.93M
-9.39%30.02M
-0.55%145.24M
-9.50%30.54M
7.70%38.78M
13.86%42.79M
-14.40%33.13M
-7.03%146.03M
0.50%33.75M
Cost of revenue
62.54%2.11M
-28.26%1.05M
-31.92%1.3M
21.55%6.01M
-10.43%1.33M
42.70%1.3M
22.70%1.47M
41.45%1.91M
-5.20%4.94M
-20.45%1.49M
Gross profit
11.87%41.93M
-10.75%36.88M
-8.01%28.71M
-1.32%139.23M
-9.45%29.21M
6.80%37.48M
13.57%41.32M
-16.42%31.22M
-7.09%141.09M
1.73%32.26M
Operating expense
-10.37%57.15M
-11.77%61.27M
-4.62%61.97M
-4.42%258.67M
-13.67%60.49M
-3.91%63.77M
5.28%69.44M
-4.79%64.97M
-7.97%270.63M
6.84%70.07M
Selling and administrative expenses
-3.71%26.61M
-8.35%28.48M
-7.44%27.35M
-12.47%115.44M
-11.40%27.19M
-10.30%27.63M
-9.89%31.07M
-17.71%29.55M
-9.30%131.88M
-11.43%30.69M
-General and administrative expense
-3.71%26.61M
-8.35%28.48M
-7.44%27.35M
-12.47%115.44M
-11.40%27.19M
-10.30%27.63M
-9.89%31.07M
-17.71%29.55M
--131.88M
--30.69M
Research and development costs
-15.47%30.54M
-14.55%32.79M
-2.28%34.62M
3.23%143.23M
-15.44%33.3M
1.63%36.13M
21.90%38.37M
9.54%35.43M
-6.67%138.75M
27.31%39.38M
Operating profit
42.09%-15.22M
13.28%-24.39M
1.49%-33.26M
7.79%-119.44M
17.26%-31.28M
15.92%-26.28M
4.91%-28.12M
-9.26%-33.76M
8.90%-129.54M
-11.63%-37.81M
Net non-operating interest income expense
-9.44%-10.46M
-51.23%-10.62M
-168.08%-9.99M
-133.09%-30.02M
-163.61%-9.72M
-187.48%-9.55M
-137.13%-7.02M
-28.15%-3.73M
43.10%-12.88M
18.96%-3.69M
Non-operating interest income
-69.81%553K
-68.24%613K
-53.62%1M
-32.38%7.4M
-41.19%1.48M
-33.38%1.83M
-31.66%1.93M
-24.32%2.16M
363.88%10.94M
88.91%2.52M
Non-operating interest expense
-3.31%11.01M
25.47%11.23M
86.85%10.99M
57.08%37.42M
80.48%11.2M
87.47%11.39M
54.72%8.95M
2.19%5.88M
-4.69%23.82M
5.49%6.21M
Other net income (expense)
-295.62%-7.42M
-103.75%-2.21M
10,014.29%19.82M
20,633.71%73.1M
4,893.36%10.11M
4,160.67%3.79M
196,560.00%59M
174.24%196K
-328.92%-356K
-1,523.08%-211K
Special income (charges)
--0
--0
----
--44.7M
--0
--0
--44.7M
----
--0
--0
-Less:Other special charges
----
----
----
---44.7M
--0
----
---44.7M
----
----
----
Other non- operating income (expenses)
-295.62%-7.42M
-115.46%-2.21M
10,014.29%19.82M
8,076.97%28.4M
4,893.36%10.11M
4,160.67%3.79M
47,553.33%14.3M
174.24%196K
-328.92%-356K
-1,523.08%-211K
Income before tax
-3.27%-33.09M
-255.97%-37.21M
37.18%-23.43M
46.51%-76.37M
25.94%-30.89M
7.10%-32.04M
173.41%23.86M
-9.45%-37.29M
13.43%-142.78M
-8.52%-41.71M
Income tax
21.43%34K
-40.30%40K
-49.30%36K
-82.35%57K
-183.85%-109K
133.33%28K
-47.24%67K
31.48%71K
-12.47%323K
78.08%130K
Net income
-3.29%-33.13M
-256.57%-37.25M
37.20%-23.46M
46.60%-76.42M
26.43%-30.78M
7.05%-32.07M
172.91%23.79M
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
Net income continuous Operations
-3.29%-33.13M
-256.57%-37.25M
37.20%-23.46M
46.60%-76.42M
26.43%-30.78M
7.05%-32.07M
172.91%23.79M
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
Minority interest income
Net income attributable to the parent company
-3.29%-33.13M
-256.57%-37.25M
37.20%-23.46M
46.60%-76.42M
26.43%-30.78M
7.05%-32.07M
172.91%23.79M
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
Preferred stock dividends
Other preferred stock dividends
5.54M
Net income attributable to common stockholders
-3.29%-33.13M
-304.11%-37.25M
37.20%-23.46M
46.60%-76.42M
26.43%-30.78M
7.05%-32.07M
155.93%18.25M
-9.48%-37.36M
13.43%-143.1M
-8.65%-41.84M
Basic earnings per share
0.78%-3.82
-291.15%-4.32
42.89%-2.77
49.60%-9.45
33.33%-3.6
14.44%-3.85
151.95%2.26
-7.78%-4.85
38.12%-18.75
16.28%-5.4
Diluted earnings per share
0.78%-3.82
-45.45%-4.32
42.89%-2.77
25.60%-13.95
33.33%-3.6
14.44%-3.85
31.72%-2.97
-7.78%-4.85
38.12%-18.75
16.28%-5.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 13.57%44.04M-11.35%37.93M-9.39%30.02M-0.55%145.24M-9.50%30.54M7.70%38.78M13.86%42.79M-14.40%33.13M-7.03%146.03M0.50%33.75M
Operating revenue 13.57%44.04M-11.35%37.93M-9.39%30.02M-0.55%145.24M-9.50%30.54M7.70%38.78M13.86%42.79M-14.40%33.13M-7.03%146.03M0.50%33.75M
Cost of revenue 62.54%2.11M-28.26%1.05M-31.92%1.3M21.55%6.01M-10.43%1.33M42.70%1.3M22.70%1.47M41.45%1.91M-5.20%4.94M-20.45%1.49M
Gross profit 11.87%41.93M-10.75%36.88M-8.01%28.71M-1.32%139.23M-9.45%29.21M6.80%37.48M13.57%41.32M-16.42%31.22M-7.09%141.09M1.73%32.26M
Operating expense -10.37%57.15M-11.77%61.27M-4.62%61.97M-4.42%258.67M-13.67%60.49M-3.91%63.77M5.28%69.44M-4.79%64.97M-7.97%270.63M6.84%70.07M
Selling and administrative expenses -3.71%26.61M-8.35%28.48M-7.44%27.35M-12.47%115.44M-11.40%27.19M-10.30%27.63M-9.89%31.07M-17.71%29.55M-9.30%131.88M-11.43%30.69M
-General and administrative expense -3.71%26.61M-8.35%28.48M-7.44%27.35M-12.47%115.44M-11.40%27.19M-10.30%27.63M-9.89%31.07M-17.71%29.55M--131.88M--30.69M
Research and development costs -15.47%30.54M-14.55%32.79M-2.28%34.62M3.23%143.23M-15.44%33.3M1.63%36.13M21.90%38.37M9.54%35.43M-6.67%138.75M27.31%39.38M
Operating profit 42.09%-15.22M13.28%-24.39M1.49%-33.26M7.79%-119.44M17.26%-31.28M15.92%-26.28M4.91%-28.12M-9.26%-33.76M8.90%-129.54M-11.63%-37.81M
Net non-operating interest income expense -9.44%-10.46M-51.23%-10.62M-168.08%-9.99M-133.09%-30.02M-163.61%-9.72M-187.48%-9.55M-137.13%-7.02M-28.15%-3.73M43.10%-12.88M18.96%-3.69M
Non-operating interest income -69.81%553K-68.24%613K-53.62%1M-32.38%7.4M-41.19%1.48M-33.38%1.83M-31.66%1.93M-24.32%2.16M363.88%10.94M88.91%2.52M
Non-operating interest expense -3.31%11.01M25.47%11.23M86.85%10.99M57.08%37.42M80.48%11.2M87.47%11.39M54.72%8.95M2.19%5.88M-4.69%23.82M5.49%6.21M
Other net income (expense) -295.62%-7.42M-103.75%-2.21M10,014.29%19.82M20,633.71%73.1M4,893.36%10.11M4,160.67%3.79M196,560.00%59M174.24%196K-328.92%-356K-1,523.08%-211K
Special income (charges) --0--0------44.7M--0--0--44.7M------0--0
-Less:Other special charges ---------------44.7M--0-------44.7M------------
Other non- operating income (expenses) -295.62%-7.42M-115.46%-2.21M10,014.29%19.82M8,076.97%28.4M4,893.36%10.11M4,160.67%3.79M47,553.33%14.3M174.24%196K-328.92%-356K-1,523.08%-211K
Income before tax -3.27%-33.09M-255.97%-37.21M37.18%-23.43M46.51%-76.37M25.94%-30.89M7.10%-32.04M173.41%23.86M-9.45%-37.29M13.43%-142.78M-8.52%-41.71M
Income tax 21.43%34K-40.30%40K-49.30%36K-82.35%57K-183.85%-109K133.33%28K-47.24%67K31.48%71K-12.47%323K78.08%130K
Net income -3.29%-33.13M-256.57%-37.25M37.20%-23.46M46.60%-76.42M26.43%-30.78M7.05%-32.07M172.91%23.79M-9.48%-37.36M13.43%-143.1M-8.65%-41.84M
Net income continuous Operations -3.29%-33.13M-256.57%-37.25M37.20%-23.46M46.60%-76.42M26.43%-30.78M7.05%-32.07M172.91%23.79M-9.48%-37.36M13.43%-143.1M-8.65%-41.84M
Minority interest income
Net income attributable to the parent company -3.29%-33.13M-256.57%-37.25M37.20%-23.46M46.60%-76.42M26.43%-30.78M7.05%-32.07M172.91%23.79M-9.48%-37.36M13.43%-143.1M-8.65%-41.84M
Preferred stock dividends
Other preferred stock dividends 5.54M
Net income attributable to common stockholders -3.29%-33.13M-304.11%-37.25M37.20%-23.46M46.60%-76.42M26.43%-30.78M7.05%-32.07M155.93%18.25M-9.48%-37.36M13.43%-143.1M-8.65%-41.84M
Basic earnings per share 0.78%-3.82-291.15%-4.3242.89%-2.7749.60%-9.4533.33%-3.614.44%-3.85151.95%2.26-7.78%-4.8538.12%-18.7516.28%-5.4
Diluted earnings per share 0.78%-3.82-45.45%-4.3242.89%-2.7725.60%-13.9533.33%-3.614.44%-3.8531.72%-2.97-7.78%-4.8538.12%-18.7516.28%-5.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.28%
Sample Name
Sample Code
 +3.09%
Sample Name
Sample Code
 +2.74%
4
Amazon
AMZN
+2.06%
5
Clean Energy Fuels
CLNE
+1.75%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +20.18%
Sample Name
Sample Code
 +8.06%
Sample Name
Sample Code
 +4.49%
4
KE Holdings
BEKE
+3.82%
5
Pony AI
PONY
+3.59%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -